Biotech

All Articles

ArsenalBio increases $325M, pivots away from past lead possession

.Collection Biosciences is going on up. The cell treatment provider has actually added on $325 thous...

Lilly- backed weight loss biotech files IPO

.After raising $170 million back in February, metabolic disease-focused BioAge Labs has filed to deb...

Aelis' marijuana make use of drug fails phase 2b, steering Indivior to re-think $100M possibility

.Aelis Farma's chances of safeguarding a fast, positive decision on a $one hundred million alternati...

ProKidney halts stage 3 trial certainly not needed to have for cell treatment approval

.ProKidney has stopped among a pair of stage 3 tests for its own cell therapy for kidney disease aft...

Vaxcyte surges on 'impressive' 31-valent PCV succeed versus Pfizer

.Vaxcyte introduced what professionals referred to as "magnificent" phase 1/2 data for its 31-valent...

Recursion's mind health condition test reveals insufficient proof of efficiency

.Recursion has actually discovered through a very early examination of its tech-enabled technique to...

Acepodia, Pfizer click together for chemistry-based tissue therapy

.Phone it an instance of really good chemical make up: Acepodia, a biotech based on Nobel Champion s...

Praxis epilepsy drug reduces seizures in stage 2 litigation

.Praxis Preciseness Medicines has actually scored an additional midphase succeed in epilepsy this ye...

Three directors surrender as Dyne blog posts mixed information for DMD applicant

.After escaping a clinical grip a number of years back, Dyne Rehab has disclosed brand-new period 1/...

Arrowhead fires off period 3 records in uncommon metabolic disease ahead of market encounter Ionis

.Arrowhead Pharmaceuticals has shown its hand ahead of a possible showdown along with Ionis, posting...